Clinical Trial

Continuous Passive Motion Versus Heterotopic Ossification

Study acronym: CPMversusHO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 6, 2024 (before its estimated April 25, 2026 completion). Its status may not reflect the trial's current state.
Summary
The investigators hypothesize that Heterotopic Ossification (HO) formation can be suppressed if the application of a Continuous Passive Motion (CPM) device can be performed for a substantial amount of time. The investigators will use the following study design: a pilot study with 10 ICU patients receiving CPM and 10 matched cases which will follow a conventional physiotherapy program at the time of the conduction of the study. The comparison between the treatment and referent groups of the outcomes will prove the prophylactic power of CPM against HO.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-06-06; most recent amendment 2024-12-04.
Trial Details
NCT Number NCT05906056
Lead Sponsor University of Ioannina
Conditions Traumatic Brain Injury, Spinal Cord Injuries, Stroke
Enrollment 20 participants
Start Date 2023-05-12
Primary Completion 2026-04-25 (estimated)
Study Completion 2027-03-25 (estimated)
Updated on ClinicalTrials.gov 2024-12-06